Mechanism of Fluconazole Resistance in Candida krusei

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736

The Carbon Monoxide-binding Pigment of Liver Microsomes

Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781

Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465

Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation

Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351

The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans

White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292

Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility

Geber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., & Bennett, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2708 · Cited by 203

The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity

Lamb, D. C., Kelly, D. E., Schunck, W., Shyadehi, A. Z., Akhtar, M., Lowe, D. J., Baldwin, B. C., & Kelly, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5682 · Cited by 192

Interaction of azole antifungal antibiotics with cytochrome P -450-dependent 14α-sterol demethylase purified from Candida albicans

Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1990) · Biochemical Journal · doi:10.1042/bj2660475 · Cited by 189

Strong Antifungal Activity of SS750, a New Triazole Derivative, Is Based on Its Selective Binding Affinity to Cytochrome P450 of Fungi

Matsumoto, M., Ishida, K., Konagai, A., Maebashi, K., & ASAOKA, T. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.308-314.2002 · Cited by 27

In Vitro Antifungal Activity and Cytotoxicity of a Novel Membrane-Active Peptide

Hong, S. Y., Oh, J. E., & Lee, K. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1704 · Cited by 26

p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis

Ferreira, P. S., Victorelli, F. D., Rodero, C. F., Fortunato, G. C., Araújo, V. H. S., Fonseca‐Santos, B., Bauab, T. M., Dijck, P. V., & Chorilli, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120658 · Cited by 25

Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole

Maheronnaghsh, M., Tolouei, S., Dehghan, P., Chadeganipour, M., & Yazdi, M. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.187394 · Cited by 25

Antifungal activity of organotin compounds with functionalized carboxylates evaluated by the microdilution bioassayin vitro

Dyląg, M., Pruchnik, H., Pruchnik, F., Majkowska-Skrobek, G., & Ułaszewski, S. (2010) · Medical Mycology · doi:10.3109/13693780903188680 · Cited by 23

Evaluation of the New Micronaut- Candida System Compared to the API ID32C Method for Yeast Identification

Szabó, Z., Tóth, B., Kovács, M., Kardos, G., Maráz, A., Rozgonyi, F., & Majoros, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02350-07 · Cited by 22

Upregulation of the ERG11 gene in Candida krusei by azoles.

Tavakoli, M., Zaini, F., Kordbacheh, M., Safara, M., Raoofian, R., & Heidari, M. (2010) · Europe PMC (PubMed Central) · Cited by 21

Studies on the inactivation of medically importantCandidaspecies on agar surfaces using pulsed light

Farrell, H., Garvey, M., & Rowan, N. J. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00543.x · Cited by 21

Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients

Fisher, B. T., & Zaoutis, T. E. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00003 · Cited by 20

In vitroeffect of DNA topoisomerase inhibitors onCandida albicans

Kwok, C. S., Schelenz, S., Wang, X., & Steverding, D. (2010) · Medical Mycology · doi:10.3109/13693780903114934 · Cited by 20

Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5

Cuomo, C. A., Shea, T., Yang, B., Rao, R. P., & Forche, A. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.043547 · Cited by 23

Antifungal activity of Syzygium samarangense leaf extracts against Candida

Raj, S. V., Vinod, V., Jayakumar, J. S., Suresh, P., Kumar, A., & Biswas, R. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13471 · Cited by 20

Antifungal therapy - state of the art at the beginning of the 21st century

Polak, A. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7974-3_4 · Cited by 19

In vitro activity of voriconazole against Candida species isolated in Taiwan

Yang, Y.-L., Cheng, H.-H., & Lo, H. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.01.014 · Cited by 18

Clinical utility of antifungal susceptibility testing

McCarty, T. P., Luethy, P. M., Baddley, J. W., & Pappas, P. G. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac067 · Cited by 17

Novel synthetic anti-fungal tripeptide effective against Candida krusei

Gill, K., Kumar, S., Xess, I., & Dey, S. (2015) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.148404 · Cited by 18

Photosensitive and pH-dependent activity of pyrazine-functionalized carbazole derivative as promising antifungal and imaging agent

Chylewska, A., Dąbrowska, A., Ramotowska, S., Maciejewska, N., Olszewski, M., Bagiński, M., & Makowski, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68758-w · Cited by 16

Factors Influencing Non-albicans Candidemia: A Case–Case–Control Study

Kofteridis, D. P., Valachis, A., Dimopoulou, D., Andrianaki, A. M., Christidou, A., Maraki, S., Spernovasilis, N. A., & Samonis, G. (2017) · Mycopathologia · doi:10.1007/s11046-017-0146-4 · Cited by 15

ERG11 mutations and upregulation in clinical itraconazole-resistant isolates of Candida krusei

Feng, W., Yang, J., Wang, Y., Chen, J., Xi, Z., & Qiao, Z. (2016) · Canadian Journal of Microbiology · doi:10.1139/cjm-2016-0055 · Cited by 14

Research advances and public health strategies in China on WHO priority fungal pathogens

Wang, Y., Han, L., Gong, J., Liu, L., Miao, B., & Xu, J. (2025) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2025.2561612 · Cited by 14

Targeted amplification and MinION nanopore sequencing of key azole and echinocandin resistance determinants of clinically relevant Candida spp. from blood culture bottles

Chew, K. L., Octavia, S., Jureen, R., Lin, R. T. P., & Teo, J. W. P. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13516 · Cited by 12

Activity of fluconazole and its Cu(II) complex towards Candida species

Ząbek, A., Nagaj, J., Grabowiecka, A., Dworniczek, E., Nawrot, U., Młynarz, P., & Jeżowska‐Bojczuk, M. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1275-7 · Cited by 13

Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.

Chiu, Y.-S., Chang, S., Hsueh, P., Wang, J., Sun, H., & Chen, Y. (2006) · PubMed · Cited by 13

Antidermatophytic Activity of the Fruticose Lichen Usnea orientalis

Pathak, A. K., Dikshit, A., & Upreti, D. K. (2016) · Medicines · doi:10.3390/medicines3030024 · Cited by 13

Antifungal activity of a maleimide derivative: disruption of cell membranes and interference with iron ion homoeostasis

Chen, C., Xie, Z., Liu, C., Mao, S., Wang, L., Wu, Y., Zhang, Y. L., Zhou, Q., Ahmad, A., Chang, W., et al. (2024) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2024.2330403 · Cited by 13

Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans

Jamiu, A. T., Albertyn, J., Sebolai, O. M., Gcilitshana, O. M. N., & Pohl, C. H. (2021) · Medical Mycology · doi:10.1093/mmy/myab055 · Cited by 13

Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans

Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 12

Candidose oropharyngée et radiothérapie

Pinel, B., Cassou‐Mounat, T., & Bensadoun, R. (2012) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2011.11.004 · Cited by 12

An emerging issue of mixed yeast cultures

Yang, Y.-L., Chu, W.-L., Lin, C.-C., Tsai, S.-H., Chang, T.-P., & Lo, H. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.01.001 · Cited by 12

Combined Antibiofilm Activity of Synthetic Peptides and Antifungal Drugs Against Candida Spp.

Bezerra, L. P., Silva, A. F. B., Santos‐Oliveira, R., Alencar, L. M. R., Amaral, J. L., Neto, N. A. S., Silva, R. G. G., Belém, M. O., de Andrade, C. R., Oliveira, J. T., et al. (2022) · Future Microbiology · doi:10.2217/fmb-2022-0053 · Cited by 12

The Fungal Resistome: A Risk and an Opportunity for the Development of Novel Antifungal Therapies

Reales‐Calderón, J. A., Molero, G., Gil, C., & Martínez, J. L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0051 · Cited by 11

Lichens: Fungal symbionts and their secondary metabolites

Devashree, Pandey, A., & Dikshit, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821005-5.00007-7 · Cited by 11

Secreted aspartate proteinases, a virulence factor ofCandida spp.: Occurrence among clinical isolates

Hamal, P., Dostál, J., Raclavský, V., Krylová, M., Pichová, I., & Hrušková‐Heidingsfeldová, O. (2004) · Folia Microbiologica · doi:10.1007/bf02931614 · Cited by 11

Epidemiology, Health Effects and Treatment of Cutaneous Mycoses of Goat and Sheep from Some Eastern States of Nigeria

Emenuga, V. N., & Oyeka, C. A. (2013) · American journal of infectious diseases and microbiology · doi:10.12691/ajidm-1-6-1 · Cited by 10

Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature

Multani, A., Subramanian, A. K., & Liu, A. Y. (2019) · Transplant Infectious Disease · doi:10.1111/tid.13118 · Cited by 10

Mechanisms of Acquired In Vivo and In Vitro Resistance to Voriconazole by Candida krusei following Exposure to Suboptimal Drug Concentration

Ricardo, E., Grenouillet, F., Miranda, I. M., Silva, R. M., Eglin, G., Devillard, N., Rodrigues, A. G., & Pina‐Vaz, C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01651-19 · Cited by 10

Resistance to Antifungal Agents

Arthington, B. A., & Rex, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72418-8_10 · Cited by 9

ERG11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients

Benedetti, V. P., Savi, D. C., Aluízio, R., Adamóski, D., Kava, V. M., Galli-Terasawa, L. V., & Glienke, C. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0473-2018 · Cited by 13

Physiological functions of multidrug transporters in yeast

Prasad, R., & Panwar, S. L. (2004) · Cited by 9

Fluconazole-Resistant Candida: Mechanisms and Risk Factor Identification

Déry, M., & Hasbun, R. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0045-3 · Cited by 9

Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans

Akins, R. A., & Sobel, J. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_30 · Cited by 9

Precision Therapy for Invasive Fungal Diseases

Märtson, A., Alffenaar, J. C., Brüggemann, R. J. M., & Hope, W. W. (2021) · Journal of Fungi · doi:10.3390/jof8010018 · Cited by 8

Diphenyl diselenide suppresses key virulence factors of Candida krusei, a neglected fungal pathogen

da Silva, B. G. M., Pinto, A. P., Passos, J. C. D. S., da Rocha, J. B. T., Alberto-Silva, C., & Costa, M. S. (2022) · Biofouling · doi:10.1080/08927014.2022.2084388 · Cited by 9

In vitro effects of Ag+ on planktonic and adhered cells of fluconazole-resistant and susceptible strains of Candida albicans, C. glabrata and C. krusei

Zhang, S., Ahearn, D. G., Mateus, C., & Crow, S. A. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.12.010 · Cited by 8

Heterogeneity of Candida bloodstream isolates in an academic medical center and affiliated hospitals

Scott, N. E., Wash, E., Zajac, C., Erayil, S. E., Kline, S. E., & Selmecki, A. M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00464-25 · Cited by 6

In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species

Schwarz, P., Nikolskiy, I., Bidaud, A.-L., Sommer, F. O., Bange, G., & Dannaoui, É. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.892893 · Cited by 7

In vitro Sensitivity to Fluconazole through Vitek II Systems, of Strains of Candida Spp. In Patients with Oropharyngeal Candidiasis and HIV/AIDS

Guzman, V. G.-F. R. Q. (2013) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000230 · Cited by 7

Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan

Yang, Y., Ho, Y.-H., Cheng, H.-H., & Lo, H. (2005) · Epidemiology and Infection · doi:10.1017/s0950268804003310 · Cited by 7

Design, synthesis and characterization of novel 1,5- and 2,5-coumarin-4-yl-methyl regioisomers of 5-pyrazol-3-yl-tetrazoles as promising anticancer and antifungal agents

Metre, T. V., Kamble, R. R., Kodasi, B., Bheemayya, L., Nadoni, V. B., Nayak, M. R., Shettar, A. K., Ahmed, K., DEVARAJEGOWDA, H. C., Joshi, S. D., et al. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138541 · Cited by 6

Review of the Current Management of Urinary Tract Infections due to Fluconazole-Resistant and Non-Albicans Candida Species

Tan, X., Baugh, K., Bulman, Z. P., & Wenzler, E. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00388-1 · Cited by 6

Antifungal drug resistance: Significance and mechanisms

Dharmaiah, S., Sherif, R., & Mukherjee, P. K. (2019) · CRC Press eBooks · doi:10.1201/9780429402012-4 · Cited by 6

In vitro evaluation of antidermatophytic activity of five lichens

Pathak, A. K., Mishra, R. K., Shukla, S. K., Kumar, R., Pandey, M., Pandey, M., Qidwai, A., & Dikshit, A. (2016) · Cogent Biology · doi:10.1080/23312025.2016.1197472 · Cited by 6

Myristica fragrans oil as a potent inhibitor of Candida albicans: Phase development inhibition and synergistic effect

Handayani, R. J., Chairunnisa, I. P. M., Forestrania, R. C., Gusmira, A., Adawiyah, R., Rozaliyani, A., Makau, J. N., Raekiansyah, M., & Rahmasari, R. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.130106 · Cited by 4

Recurring Events ofCandida kruseiSepticaemia: First Report from an ICU

Duggal, S. D., Jena, P. P., Gur, R., Kumar, A., Rongpharpi, S. R., Pandey, M., Xess, I., & Wadhwa, V. (2015) · Journal of Mycology · doi:10.1155/2015/721424 · Cited by 5

Antifungal Drug Resistance: Pumps and Permutations

White, T. C., Harry, J. B., & Oliver, B. G. G. (2004) · Springer eBooks · doi:10.1007/978-3-662-10380-7_17 · Cited by 5

In vitroactivity of fluconazole and amphotericin B againstCandida inconspicuaclinical isolates as determined by the time-kill method

Szabó, Z., Sóczó, G., Miszti, C., Hermann, P., & Rozgonyi, F. (2008) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.55.2008.1.4 · Cited by 5

EVALUATION OF VITEK 2 SYSTEM FOR CLINICAL IDENTIFICATION OF CANDIDA SPECIES AND THEIR ANTIFUNGAL SUSCEPTIBILITY TEST

Sundaram, M., & Navaneethakrishnan, R. M. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/687 · Cited by 5

Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against Candida glabrata

Schwarz, P., Nikolskiy, I., Dannaoui, É., Sommer, F., Bange, G., & Schwarz, P. (2022) · Journal of Fungi · doi:10.3390/jof8050525 · Cited by 5

Metal (II) Complexes of Fluconazole: Thermal, XRD and Cytotoxicity Studies.

Ali, S. I., Lei, Z., Ali, M., Kojima, K. K. K., Ahmed, M., Peng, R., Yang, D., Haider, S. M., Ayatollahi, S. A., & Chen, Z. (2020) · PubMed Central · doi:10.22037/ijpr.2020.1101142 · Cited by 6

Bixin from Bixa orellana L.: Analytical Method Validation, Physicochemical Characterization, and Selective Antifungal Activity against Candida spp.

Rodrigues, D. F., Vieira, M., Júnior, M. A. F. M., Thomasi, R. M. D. O., Sinisterra, R. D., Garcia, E. D. F., do Couto, R. O., Lima, W. G., de Paiva, M. C., & Jensen, C. E. D. M. (2025) · ACS Omega · doi:10.1021/acsomega.5c04986 · Cited by 4

Embryotoxicity of fluconazole on developing chick embryos

Sattar, R. Z., Bilal, A., Bashir, S., Iftikhar, A., & Yaqoob, I. (2024) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-024-00359-9 · Cited by 4

Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei

Costa, I. D., Lopes, I., Morais, M., Silva, R. V. D. S., Remião, F., Medeiros, R., Alves, L. G., Pinto, E., & Cerqueira, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105209 · Cited by 4

Synthesis and Antifungal Activity Evaluation of 1-sulfonyl-1,2,3-triazoles

García-Vanegas, J. J., Rodríguez-Florencio, J., Cifuentes-Castañeda, D. D., Zerón, H. M., Pavón-Romero, S., Morales-Rodríguez, M., Corona‐Becerril, D., & Cuevas‐Yáñez, E. (2021) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-021-02460-7 · Cited by 4

(MeOPhSe)2, a synthetic organic selenium compound, inhibits virulence factors of Candida krusei: Adherence to cervical epithelial cells and biofilm formation

de Siqueira, V. M., da Silva, B. G. M., Passos, J. C. D. S., Pinto, A. P., da Rocha, J. B. T., Alberto-Silva, C., & Costa, M. S. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127019 · Cited by 4

Evolution ofMATin theCandidaSpecies Complex: Sex, Ploidy, and Complete Sexual Cycles inC. lusitaniae, C. guilliermondii, andC. krusei

Reedy, J. L., & Heitman, J. (2014) · ASM Press eBooks · doi:10.1128/9781555815837.ch14 · Cited by 4

Mucocutaneous and Deeply Invasive Candidiasis

Shoham, S., Nucci, M., & Walsh, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00088-4 · Cited by 4

Potassium uptake systems of Candida krusei

Elicharová, H., Herynkova, P., Zimmermannová, O., & Sychrová, H. (2019) · Yeast · doi:10.1002/yea.3396 · Cited by 4

Impact of the New Clinical Breaking Points Proposed by the Clinical and Laboratory Standards Institute (CLSI) in the Antifungal Susceptibility Profile of Clinical Strains Isolated from Invasive Bloodstream Candida Spp. Infections in Spain

Cisterna, R., Tellería, O., Hernáez, S., & Ezpeleta, G. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s8293 · Cited by 3

Candida profile in HIV-Positive children needs a Dynamic clinical appraisal: A microbiological Study

Sneha, K. H., Natarajan, S., Boaz, K., Ramapuram, J., Baliga, S., Manaktala, N., & Chitra, N. S. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00072 · Cited by 3

Phenotypic and genotypic assessment of Lactobacillus plantarum influence on Candida albicans fluconazole resistance

Sârbu, I., Vassu, T., Stoica, I., Dascălu, L., Chifiriuc, M. C., & Pelinescu, D. R. (2015) · Annals of Microbiology · doi:10.1007/s13213-015-1159-1 · Cited by 3

ABC and MFS Transporters: A reason for Antifungal drug resistance

Neelabh, D., & Singh, K. (2018) · Archives of Biotechnology and Biomedicine · doi:10.29328/journal.abb.1001009 · Cited by 4

Prevalence of yeast fungal infections in intensive care unit in PolandPreprint

Francuzik, W., Skłodowska, A., Adamska, K., Adamski, Z., Tamowicz, B., & Mikstacki, A. (2015) · doi:10.7287/peerj.preprints.785v1 · Cited by 3

Species-Specific Susceptibility of Planktonic and Biofilm Forming Candida Strains to Cyclodextrin-Encapsulated Essential Oils

Das, S., Baradarbarjastehbaf, F., Szokolics, A. S., Campos, G. K. D., Gazdag, Z., Széchenyi, A., Miseta, A., Kovács, G. L., & Kőszegi, T. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040508 · Cited by 2

Epidemiology of urinary candidiasis and antifungal susceptibility pattern of various Candida species at a rural tertiary health care centre of Puducherry, South India- An observational study

Ranganathan, U., Rafi, N., Rangasamy, G., Thiyagarajan, M., & Shivekar, S. (2021) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2021.023 · Cited by 2

Distribution of clinical yeasts in Taiwan

Lo, H., Cheng, H.-H., & Hospitals, T. (2005) · Fungal science · doi:10.7099/fs.200512.0083 · Cited by 2

Candida Infections: An Update on Host Immune Defenses and Anti-Fungal Drugs

Gao, N., & Chen, C. (2016) · doi:10.11979/idtm.201601005 · Cited by 2

Antifungal Drug Resistance

Mukherjee, P. K., & Wang, M. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-5 · Cited by 2

Dermatomicosis por Candida krusei simulando herpes cutáneo

Sanz-Santaeufemia, F. J., Talavera, M., Gónzález, I. G., & del Río, R. G. (2015) · Pediatría Atención Primaria · doi:10.4321/s1139-76322015000100013 · Cited by 2

Viabilização da curcumina natural nanoencapsulada para inativação fotodinâmica

Suzuki, I. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.76.2016.tde-01042016-143506 · Cited by 2

Resistance to Antifungal Agents

Arıkan, S., & Rex, J. H. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0136 · Cited by 2

Utilization Management in a Large Community Hospital

Kiechle, F. L., & Arcenas, R. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34199-6_14 · Cited by 1

Candida krusei: A Useful Yeast for Production of Second-Generation Bioethanol

Akita, H., & Matsushika, A. (2026) · Biomass · doi:10.3390/biomass6030042 · Cited by 1

Multidrug Resistance in Fungi: The Role of Pleiotropic Drug Resistance Genes

Sharma, S., & Ganesan, K. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_8 · Cited by 1

Candidiasis and the impact of flow cytometry on antifungal drug discovery

Ku, T. S. N., Bernardo, S. M., Walraven, C. J., & Lee, S. A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1377179 · Cited by 1

Allylic Selenocyanates as Antifungal Agents Against Pathogenic Candida Species

Bazana, L. C. G., Carvalho, Â. R., Silveira, G. P., de Oliveira, L. F. S., Teixeira, M. L., Lopes, W., Vainstein, M. H., Barbosa, F. A. R., Russo, T. V. C., Sá, M. M., et al. (2020) · ChemistrySelect · doi:10.1002/slct.202002170 · Cited by 1

Nanotechnology-Based Strategies for Combating Emerging and Re-emerging Fungal Infections

Asghari-Paskiabi, F., & Jahanshiri, Z. (2024) · Motaleat-e Tatbiqi-e Honar · doi:10.61186/jommid.12.1.1 · Cited by 2

Susceptibilidade antifúngica, produção de biofilme e caracterização do gene ALS3 em isolados de Candida albicans e não-albicans do hospital das clínicas, UNESP, Botucatu

Nascimento, A. C. M. D. O. B. (2009) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences · Cited by 1

New antifungal therapies

Proia, L. A. (2006) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2006.11.001 · Cited by 1

Species Distribution and Drug Susceptibility of Candida Isolates from Various Clinical Specimens at a Tertiary Care Hospital in Kashmir

Nazir, A., Kanth, F., & Farhana, A. (2016) · British Microbiology Research Journal · doi:10.9734/bmrj/2016/24548 · Cited by 1

Caracterización de Candida spp. aisladas a partir de urocultivos en la ciudad de Medellín

Duque, C., Sánchez, D. M., Gaviria, Á. M., Acosta, A. V., Gómez, B. L., Gómez, O. M., Giraldo, Á., & Hernández, O. (2020) · Infectio · doi:10.22354/in.v24i4.879 · Cited by 5

Antifungal Resistance: Current Concepts

Singh, G., & Xess, I. (2020) · Springer eBooks · doi:10.1007/978-981-15-3658-8_7 · Cited by 2

Azoles

Cottom, L., & McPhee, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00133-x · Cited by 1

Fungal Communities in Oral Health and Disease

Dupuy, A. K. (2015) · OpenCommons - UConn (University of Connecticut)

Candida krusei Lung Abscess in an Immunocompetent Man

Lammi, M. R., & Moyer, D. V. (2009) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31817b60e0

Update on antifungal treatment in neutropenic patients

Hung, I. F. (2008) · The HKU Scholars Hub (University of Hong Kong)

Candida Infection in Intensive Care Unit Patients at Tertiary Care Hospital

Barot, N., Vegad, M. M., Soni, S. T., Sharma, K., & Shah, K. H. (2015) · Healthline

Mechanisms of Action of Antifungal Agents

Flowers, S. A., & Rogers, P. (2015) · CRC Press eBooks · doi:10.1201/b17871-14

Emerging Resistance AmongCandidaSpecies: Trends and Treatment Considerations for Candidemia

Lee, I., & Zaoutis, T. E. (2007) · Infectious disease and therapy · doi:10.3109/9781420017236.012

ERG11-Mediated Azole Resistance in Candida albicans

Flowers, S. A. (2013) · doi:10.21007/etd.cghs.2013.0096

Inhibition and interaction of cytochrome P450 ofCandida kruseiwith azole antifungal drugs

Venkateswarlu, K., Denning, D. W., & Kelly, S. (1997) · Medical Mycology · doi:10.1080/02681219780000821 · Cited by 31

Fluconazole resistance mechanisms inCandida krusei: The contribution of efflux-pumps

Guinea, J., Sánchez-Somolinos, M., Cuevas, Ó., Peláez, T., & Bouza, E. (2006) · Medical Mycology · doi:10.1080/13693780600561544 · Cited by 58

Short Communication Fluconazole resistance mechanisms in Candida krusei: The contribution of efflux-pumps

Guinea, J., Cuevas, O., & Bouza, E. (2016)

Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2443 · Cited by 58

Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei

Fukuoka, T., Johnston, D. A., Winslow, C. A., de Groot, M. J., Burt, C., Hitchcock, C. A., & Filler, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1213-1219.2003 · Cited by 97